Table 1.
Baseline characteristics.
| (A)
| ||||||||
|---|---|---|---|---|---|---|---|---|
| ID | Ethnicity | Gender | ALT | Albumin | Tbili | INR | Platelet | Etiology |
| CIR004 | H | M | 34 | 4 | 0.6 | 1.2 | 169 | HCV |
| CIR026 | B | M | 63 | 3.4 | 0.7 | 1 | 147 | HCV |
| CIR029 | W | M | 77 | 4.3 | 0.9 | 1.1 | 151 | HCV |
| CIR031 | H | M | 28 | 3.8 | 0.6 | 1.1 | 151 | HCV |
| CIR034 | W | M | 73 | 3.8 | 1 | 1.1 | 53 | HCV |
| CIR037 | B | M | 51 | 3.5 | 0.6 | 1 | 122 | HCV |
| CIR019 | B | M | 23 | 3.7 | 0.5 | 1.2 | 160 | HBV |
| CIR018 | W | M | 19 | 4.4 | 1.1 | 1.1 | 109 | EtOH |
| CIR041 | W | M | 27 | 3.9 | 0.6 | 1 | 206 | EtOH |
| CIR042 | W | M | 28 | 4.3 | 0.7 | 1.1 | 87 | EtOH |
| CIR036 | W | M | 36 | 4.5 | 0.9 | 1 | 198 | HFE |
| CIR038 | W | M | 15 | 3.7 | 0.6 | 1.1 | 146 | HFE |
| CIR035 | W | M | 98 | 4.5 | 0.7 | 1 | 175 | NASH |
| CIR043 | W | M | 31 | 3.7 | 1.4 | 1.2 | 52 | NASH |
| CIR030 | W | M | 52 | 4.4 | 0.7 | 1 | 145 | NASH/EtOH |
| (B)
| |||
|---|---|---|---|
| Healthy donor | Cirrhotic patients | p value | |
| Number of patients | |||
| Number of patients | |||
| Median age (years, IQR) | 53 (38–56) | 62 (56–65) | 0.02 |
| Ethnicity (W/B/H) | 6/1/0 | 10/3/2 | n.s |
| Gender (M/F) | 5/2 | 15/0 | n.s |
| Median alanine aminotransferase (IU/L) (IQR) | 20 (17–31) | 34 (27–63) | 0.04 |
| Median albumin (g/dl) (IQR) | 4.2 (4.1–4.3) | 3.9 (3.7–4.4) | n.s |
| Median total bilirubin (mg/dl) (IQR) | 0.7 (0.5–1.2) | 0.7 (0.6–0.9) | n.s |
| Median INR (IQR) | 1.1 (1.0–1.2) | 1.1 (1.0–1.1) | n.s |
| Median platelet count (×103/μl) (IQR) | 196 (176–271) | 147 (109–169) | 0.004 |
| Etiology (viral/metabolic) | – | 7/8 | |
n.s: not significant.